Business

January 6, 2014

Oxygen Bio's stock surges after company releases clinical trial details

Oxygen Biotherapeutics stock jumped 16 percent Monday after the Morrisville company announced details of late-stage clinical trials for its cardiovascular drug.

Related content

Comments

Editor's Choice Videos